CAMDEN PROPERTY TRUST (CPT) Stock Fundamental Analysis
USA - NYSE:CPT - US1331311027 - REIT
101.85 USD
+0.15 (+0.15%)
101.85 USD
0 (0%)
CPT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 20 industry peers in the Residential REITs industry. There are concerns on the financial health of CPT while its profitability can be described as average. While showing a medium growth rate, CPT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
CPT had positive earnings in the past year.
CPT had a positive operating cash flow in the past year.
CPT had positive earnings in each of the past 5 years.
Each year in the past 5 years CPT had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.71%, CPT is in line with its industry, outperforming 60.00% of the companies in the same industry.
CPT's Return On Equity of 3.39% is in line compared to the rest of the industry. CPT outperforms 55.00% of its industry peers.
With a Return On Invested Capital value of 2.66%, CPT perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CPT is in line with the industry average of 2.59%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.71% | ||
| ROE | 3.39% | ||
| ROIC | 2.66% |
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
1.3 Margins
CPT has a Profit Margin of 9.97%. This is comparable to the rest of the industry: CPT outperforms 60.00% of its industry peers.
In the last couple of years the Profit Margin of CPT has declined.
With a Operating Margin value of 18.78%, CPT perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CPT has declined.
The Gross Margin of CPT (61.19%) is better than 75.00% of its industry peers.
In the last couple of years the Gross Margin of CPT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.78% | ||
| PM (TTM) | 9.97% | ||
| GM | 61.19% |
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CPT is destroying value.
Compared to 1 year ago, CPT has less shares outstanding
CPT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CPT has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.51, we must say that CPT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CPT (1.51) is better than 75.00% of its industry peers.
The Debt to FCF ratio of CPT is 9.23, which is on the high side as it means it would take CPT, 9.23 years of fcf income to pay off all of its debts.
CPT has a better Debt to FCF ratio (9.23) than 95.00% of its industry peers.
CPT has a Debt/Equity ratio of 0.83. This is a neutral value indicating CPT is somewhat dependend on debt financing.
CPT has a Debt to Equity ratio of 0.83. This is in the better half of the industry: CPT outperforms 65.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 9.23 | ||
| Altman-Z | 1.51 |
ROIC/WACC0.37
WACC7.24%
2.3 Liquidity
CPT has a Current Ratio of 0.10. This is a bad value and indicates that CPT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.10, CPT is doing worse than 80.00% of the companies in the same industry.
CPT has a Quick Ratio of 0.10. This is a bad value and indicates that CPT is not financially healthy enough and could expect problems in meeting its short term obligations.
CPT has a worse Quick ratio (0.10) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.1 | ||
| Quick Ratio | 0.1 |
3. Growth
3.1 Past
CPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -62.09%.
CPT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.43% yearly.
The Revenue has been growing slightly by 0.77% in the past year.
The Revenue has been growing by 8.46% on average over the past years. This is quite good.
EPS 1Y (TTM)-62.09%
EPS 3Y13.97%
EPS 5Y0.43%
EPS Q2Q%-22.5%
Revenue 1Y (TTM)0.77%
Revenue growth 3Y10.52%
Revenue growth 5Y8.46%
Sales Q2Q%2.42%
3.2 Future
Based on estimates for the next years, CPT will show a small growth in Earnings Per Share. The EPS will grow by 1.21% on average per year.
Based on estimates for the next years, CPT will show a small growth in Revenue. The Revenue will grow by 4.51% on average per year.
EPS Next Y-18.57%
EPS Next 2Y-11.25%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year2.44%
Revenue Next 2Y2.53%
Revenue Next 3Y3.29%
Revenue Next 5Y4.51%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 73.80 indicates a quite expensive valuation of CPT.
CPT's Price/Earnings ratio is in line with the industry average.
CPT is valuated expensively when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 68.78 indicates a quite expensive valuation of CPT.
The rest of the industry has a similar Price/Forward Earnings ratio as CPT.
CPT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 73.8 | ||
| Fwd PE | 68.78 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CPT is valued a bit cheaper than 80.00% of the companies in the same industry.
85.00% of the companies in the same industry are more expensive than CPT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.27 | ||
| EV/EBITDA | 16.57 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)171.22
EPS Next 2Y-11.25%
EPS Next 3Y1.21%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.12%, CPT is a good candidate for dividend investing.
CPT's Dividend Yield is slightly below the industry average, which is at 6.43.
CPT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.12% |
5.2 History
The dividend of CPT has a limited annual growth rate of 4.99%.
CPT has been paying a dividend for at least 10 years, so it has a reliable track record.
CPT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.99%
Div Incr Years7
Div Non Decr Years14
5.3 Sustainability
293.28% of the earnings are spent on dividend by CPT. This is not a sustainable payout ratio.
CPT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP293.28%
EPS Next 2Y-11.25%
EPS Next 3Y1.21%
101.85
+0.15 (+0.15%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)
Earnings (Next)
Inst Owners96.78%
Inst Owner Change-0.03%
Ins Owners1.25%
Ins Owner Change-0.27%
Market Cap10.88B
Analysts73.1
Price Target124.38 (22.12%)
Short Float %2.76%
Short Ratio3.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.12% |
Yearly Dividend4.15
Dividend Growth(5Y)4.99%
DP293.28%
Div Incr Years7
Div Non Decr Years14
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.57%
Min EPS beat(2)-0.59%
Max EPS beat(2)5.72%
EPS beat(4)1
Avg EPS beat(4)-4.05%
Min EPS beat(4)-12.31%
Max EPS beat(4)5.72%
EPS beat(8)4
Avg EPS beat(8)60.9%
EPS beat(12)7
Avg EPS beat(12)54.23%
EPS beat(16)8
Avg EPS beat(16)82.47%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.57%
Max Revenue beat(2)-0.45%
Revenue beat(4)0
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)-0.45%
Revenue beat(8)0
Avg Revenue beat(8)-0.95%
Revenue beat(12)0
Avg Revenue beat(12)-0.89%
Revenue beat(16)3
Avg Revenue beat(16)5.31%
PT rev (1m)-1.08%
PT rev (3m)-6.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.37%
EPS NY rev (1m)21.5%
EPS NY rev (3m)17.73%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 73.8 | ||
| Fwd PE | 68.78 | ||
| P/S | 6.97 | ||
| P/FCF | 26.27 | ||
| P/OCF | 13.73 | ||
| P/B | 2.37 | ||
| P/tB | 2.37 | ||
| EV/EBITDA | 16.57 |
EPS(TTM)1.38
EY1.35%
EPS(NY)1.48
Fwd EY1.45%
FCF(TTM)3.88
FCFY3.81%
OCF(TTM)7.42
OCFY7.28%
SpS14.61
BVpS42.93
TBVpS42.93
PEG (NY)N/A
PEG (5Y)171.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.71% | ||
| ROE | 3.39% | ||
| ROCE | 3.37% | ||
| ROIC | 2.66% | ||
| ROICexc | 2.67% | ||
| ROICexgc | 2.75% | ||
| OM | 18.78% | ||
| PM (TTM) | 9.97% | ||
| GM | 61.19% | ||
| FCFM | 26.55% |
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
ROICexc(3y)2.77%
ROICexc(5y)2.72%
ROICexgc(3y)2.85%
ROICexgc(5y)2.8%
ROCE(3y)3.46%
ROCE(5y)3.32%
ROICexcg growth 3Y0.86%
ROICexcg growth 5Y-2.21%
ROICexc growth 3Y1.1%
ROICexc growth 5Y-2.02%
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
F-Score4
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 9.23 | ||
| Debt/EBITDA | 4.32 | ||
| Cap/Depr | 63.86% | ||
| Cap/Sales | 24.25% | ||
| Interest Coverage | 2.12 | ||
| Cash Conversion | 89.5% | ||
| Profit Quality | 266.19% | ||
| Current Ratio | 0.1 | ||
| Quick Ratio | 0.1 | ||
| Altman-Z | 1.51 |
F-Score4
WACC7.24%
ROIC/WACC0.37
Cap/Depr(3y)72.34%
Cap/Depr(5y)87.06%
Cap/Sales(3y)27.91%
Cap/Sales(5y)32.43%
Profit Quality(3y)124.82%
Profit Quality(5y)99.59%
High Growth Momentum
Growth
EPS 1Y (TTM)-62.09%
EPS 3Y13.97%
EPS 5Y0.43%
EPS Q2Q%-22.5%
EPS Next Y-18.57%
EPS Next 2Y-11.25%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)0.77%
Revenue growth 3Y10.52%
Revenue growth 5Y8.46%
Sales Q2Q%2.42%
Revenue Next Year2.44%
Revenue Next 2Y2.53%
Revenue Next 3Y3.29%
Revenue Next 5Y4.51%
EBIT growth 1Y-7.46%
EBIT growth 3Y9.54%
EBIT growth 5Y3.5%
EBIT Next Year207.48%
EBIT Next 3Y49.06%
EBIT Next 5Y37.61%
FCF growth 1Y7.34%
FCF growth 3Y36.84%
FCF growth 5Y20.83%
OCF growth 1Y1.55%
OCF growth 3Y10.3%
OCF growth 5Y6.88%